miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world setting by Yilan Xu, Danyang Li, Na Wang, Bei Ge, Chen Meng, Min Zhao, Zihan Lin, Min Li, Yigang Yuan, Yue Cai, Liuzhi Shi, Shenmeng Gao, Haige Ye

Get full text

POD24-Based prognostic signature enables personalized risk stratification in mantle cell lymphoma by Yizi He, Caiqin Wang, Tao Pan, Qingqing Cai, Dehui Zhou, Huilai Zhang, Rong Liang, Dongfeng Zeng, Haige Ye, Yun Liang, Xiuhua Sun, Ling Xiao, Hui Zhou

Get full text

Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China by Rongqi Li, Rongqi Li, Yuhan Zeng, Yuhan Zeng, Yizhang Chen, Yizhang Chen, Zhongjiang Ye, Zhongjiang Ye, Chuang Chen, Chuang Chen, Jianhui Yang, Jianhui Yang, Jing Fu, Jing Fu, Tao Zhou, Tao Zhou, Danna Jiang, Danna Jiang, Sunting Qin, Sunting Qin, Haige Ye, Ziye Zhou, Ziye Zhou, Xiuhua Zhang

Get full text